Acorah Software Products - Accounts Production 15.0.600 false true 28 February 2023 1 March 2022 false true No description of principal activity 1 March 2023 28 February 2024 28 February 2024 12483097 Mr E Haroun iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12483097 2023-02-28 12483097 2024-02-28 12483097 2023-03-01 2024-02-28 12483097 frs-core:CurrentFinancialInstruments 2024-02-28 12483097 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 12483097 frs-bus:FilletedAccounts 2023-03-01 2024-02-28 12483097 frs-bus:Micro-entities 2023-03-01 2024-02-28 12483097 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 12483097 frs-bus:Director1 2023-03-01 2024-02-28 12483097 2022-02-28 12483097 2023-02-28 12483097 2022-03-01 2023-02-28 12483097 frs-core:CurrentFinancialInstruments 2023-02-28
Registered number: 12483097
Eh Pharma Limited
Unaudited Financial Statements
For The Year Ended 28 February 2024
Balance Sheet
Registered number: 12483097
2024 2023
£ £
Current assets 11,957 615
Creditors: Amounts Falling Due Within One Year (10,889 ) (3,738 )
NET CURRENT ASSETS (LIABILITIES) 1,068 (3,123 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,068 (3,123 )
NET ASSETS/(LIABILITIES) 1,068 (3,123 )
CAPITAL AND RESERVES 1,068 (3,123 )

Notes

1. General Information
Eh Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12483097 . The registered office is 14 Blossom Close, Ealing, W5 4YF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
Page 0
Page 1
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr E Haroun
Director
28th November 2024